This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Csl Behring Lengnau Ag. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: The Innovations of Hans-Wilhelm Beltz
Introduction
Hans-Wilhelm Beltz is a notable inventor based in Biedenkopf, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of coagulation disorders. With a total of three patents to his name, Beltz has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Among his latest patents, Beltz has developed methods for preparing modified von Willebrand Factor. This invention provides modified von Willebrand Factor molecules, along with methods for their preparation and various uses. Additionally, the invention includes pharmaceutical compositions aimed at treating coagulation disorders. These advancements highlight his dedication to improving treatment options for patients with blood-related conditions.
Career Highlights
Beltz is currently associated with CSL Behring Lengnau AG, a company known for its focus on biopharmaceuticals. His work at this organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research. His career reflects a strong emphasis on innovation and the application of scientific knowledge to real-world medical challenges.
Collaborations
Some of his notable coworkers include Stefan Schulte and Sabine Pestel. Their collaboration has likely fostered an environment of creativity and shared expertise, further enhancing the impact of their collective work.
Conclusion
Hans-Wilhelm Beltz is a distinguished inventor whose work in the field of coagulation disorders has the potential to transform patient care. His innovative patents and contributions to CSL Behring Lengnau AG underscore his role as a leader in biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile